ArticleFrontiers in immunology2018

CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance.

Anja Seckinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.